Occurrence of Total and Proteinase K-Resistant Alpha-Synuclein in Glioblastoma Cells Depends on mTOR Activity.

autophagy vacuoles cell-clearing systems glioblastoma multiforme mechanistic target of rapamycin qRT-PCR siRNA synucleins transmission electron microscopy

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
08 Mar 2022
Historique:
received: 11 01 2022
revised: 01 03 2022
accepted: 07 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 26 3 2022
Statut: epublish

Résumé

Alpha-synuclein (α-syn) is a protein considered to be detrimental in a number of degenerative disorders (synucleinopathies) of which α-syn aggregates are considered a pathological hallmark. The clearance of α-syn strongly depends on autophagy, which can be stimulated by inhibiting the mechanistic target of rapamycin (mTOR). Thus, the overexpression of mTOR and severe autophagy suppression may produce α-syn accumulation, including the proteinase K-resistant protein isoform. Glioblastoma multiforme (GBM) is a lethal brain tumor that features mTOR overexpression and severe autophagy inhibition. Cell pathology in GBM is reminiscent of a fast, progressive degenerative disorder. Therefore, the present work questions whether, as is analogous to neurons during degenerative disorders, an overexpression of α-syn occurs within GBM cells. A high amount of α-syn was documented in GBM cells via real-time PCR (RT-PCR), Western blotting, immunohistochemistry, immuno-fluorescence, and ultrastructural stoichiometry, compared with the amount of β- and γ-synucleins and compared with the amount of α-syn counted within astrocytes. The present study indicates that (i) α-syn is overexpressed in GBM cells, (ii) α-syn expression includes a proteinase-K resistant isoform, (iii) α-syn is dispersed from autophagy-like vacuoles to the cytosol, (iv) α-syn overexpression and cytosol dispersion are mitigated by rapamycin, and (v) the α-syn-related GBM-like phenotype is mitigated by silencing the SNCA gene.

Identifiants

pubmed: 35326535
pii: cancers14061382
doi: 10.3390/cancers14061382
pmc: PMC8946689
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministero della Salute
ID : Ricerca Corrente 2021

Références

Acta Neuropathol. 2000 Feb;99(2):154-60
pubmed: 10672322
Int J Biochem Cell Biol. 2015 Jul;64:25-33
pubmed: 25813876
Oncol Rep. 2010 Feb;23(2):429-36
pubmed: 20043104
Science. 1997 Jun 27;276(5321):2045-7
pubmed: 9197268
Oncotarget. 2015 Jun 30;6(18):15882-90
pubmed: 26021816
J Histochem Cytochem. 2001 Dec;49(12):1519-24
pubmed: 11724899
Int J Mol Sci. 2020 Jun 27;21(13):
pubmed: 32604996
Neuro Oncol. 2010 Dec;12(12):1205-19
pubmed: 20861085
Neuron. 2013 Sep 18;79(6):1044-66
pubmed: 24050397
Acta Neuropathol Commun. 2020 Jun 19;8(1):86
pubmed: 32560668
Oncotarget. 2017 May 2;8(18):29574-29599
pubmed: 28418837
Acta Neuropathol. 1994;87(1):86-90
pubmed: 7908155
Neuropharmacology. 2014 Jul;82:132-42
pubmed: 23973294
Int J Mol Sci. 2016 Feb 02;17(2):
pubmed: 26848654
Sci Rep. 2019 Jul 29;9(1):10919
pubmed: 31358782
Science. 2003 Oct 31;302(5646):841
pubmed: 14593171
Cold Spring Harb Perspect Med. 2018 Mar 1;8(3):
pubmed: 28108534
Brain Res Mol Brain Res. 1991 Oct;11(3-4):335-43
pubmed: 1661825
PLoS One. 2011;6(5):e19622
pubmed: 21611169
J Microsc. 2000 Jul;199(Pt 1):1-36
pubmed: 10886526
Sci Rep. 2021 Mar 4;11(1):5267
pubmed: 33664298
Dis Model Mech. 2022 Mar 1;15(3):
pubmed: 35023548
Curr Protein Pept Sci. 2018;19(6):598-611
pubmed: 29150919
J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1554-63
pubmed: 24780412
Arch Ital Biol. 2012 Jun-Sep;150(2-3):194-217
pubmed: 23165879
Adv Biol Regul. 2013 May;53(2):202-10
pubmed: 23231881
Mov Disord. 2003 Sep;18 Suppl 6:S21-7
pubmed: 14502652
J Cell Sci. 2013 Jan 15;126(Pt 2):696-704
pubmed: 23203798
Brain Res. 2002 Jun 21;941(1-2):118-26
pubmed: 12031554
Front Neuroanat. 2016 Jul 21;10:78
pubmed: 27493626
JAMA Neurol. 2013 May;70(5):571-9
pubmed: 23459986
Geroscience. 2021 Oct;43(5):2413-2425
pubmed: 34482522
Biochem J. 2017 Jun 6;474(12):2039-2049
pubmed: 28495859
Brain Res. 2010 Feb 8;1313:250-8
pubmed: 20004652
Methods Enzymol. 2009;453:273-86
pubmed: 19216911
Brain Res. 2013 Feb 7;1495:37-51
pubmed: 23261661
J Cereb Blood Flow Metab. 2011 Mar;31(3):913-23
pubmed: 20877387
J Histochem Cytochem. 1999 Nov;47(11):1465-70
pubmed: 10544219
Biochem Biophys Res Commun. 2020 Feb 12;522(3):655-661
pubmed: 31785806
Neuroscience. 2021 Aug 1;468:186-198
pubmed: 34082066
Science. 2001 Feb 16;291(5507):1363-5
pubmed: 11233453
J Neurosci. 2016 Jun 29;36(26):7055-65
pubmed: 27358461
Chemistry. 2018 Oct 17;24(58):15685-15690
pubmed: 30102440
Lancet Neurol. 2011 Nov;10(11):1015-25
pubmed: 22014436
Ann Neurol. 2000 Feb;47(2):201-10
pubmed: 10665491
Int J Mol Sci. 2021 May 20;22(10):
pubmed: 34065350
PLoS One. 2010 May 05;5(5):e10481
pubmed: 20463956
Brain Res. 2019 Sep 15;1719:157-175
pubmed: 31150652
Mov Disord Clin Pract. 2017 Jun 01;4(5):724-732
pubmed: 30363411
Acta Neuropathol. 2003 Aug;106(2):167-75
pubmed: 12783249
Hum Mol Genet. 2011 Sep 1;20(17):3401-14
pubmed: 21642386
Int J Cancer. 2011 Dec 1;129(11):2720-31
pubmed: 21384342
Nature. 2013 Jun 13;498(7453):E4-6; discussion E6-7
pubmed: 23765500
Toxicol Lett. 2021 Nov 1;352:34-45
pubmed: 34562559
J Neural Transm Suppl. 2000;(58):53-63
pubmed: 11128613
Neuropathol Appl Neurobiol. 2016 Feb;42(1):6-19
pubmed: 26750431
Trends Neurosci. 2017 Jun;40(6):358-370
pubmed: 28527591
Histol Histopathol. 2017 May;32(5):413-431
pubmed: 27775777
Brain Pathol. 2002 Jan;12(1):1-11
pubmed: 11770893
J Histochem Cytochem. 2004 Aug;52(8):991-1000
pubmed: 15258174
J Neurosci. 2020 Nov 4;40(45):8618-8628
pubmed: 33046546
Autophagy. 2021 Jan;17(1):1-382
pubmed: 33634751
Brain. 2017 Apr 1;140(4):878-886
pubmed: 27585855
Histochem Cell Biol. 2008 Aug;130(2):299-313
pubmed: 18553098
Hum Mol Genet. 2019 Jul 15;28(14):2283-2294
pubmed: 31267130
Neurobiol Aging. 2003 Sep;24(5):687-96
pubmed: 12885576
Clin Pharmacokinet. 2004;43(2):83-95
pubmed: 14748618
Hum Mol Genet. 2019 Jan 1;28(1):31-50
pubmed: 30219847
Brain Res. 2007 Jan 19;1129(1):174-90
pubmed: 17157274
J Mol Med (Berl). 2006 Nov;84(11):901-10
pubmed: 16972087
Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S62-7
pubmed: 24262191
J Clin Oncol. 2004 May 15;22(10):1926-33
pubmed: 15143086
J Adv Res. 2020 Jan 22;23:37-45
pubmed: 32071790
Int J Mol Sci. 2021 Oct 27;22(21):
pubmed: 34769043
J Neurochem. 2012 Aug;122(4):812-22
pubmed: 22639889
Int J Mol Sci. 2019 Aug 05;20(15):
pubmed: 31387280
J Biol Chem. 2003 Jul 4;278(27):25009-13
pubmed: 12719433
Transl Neurodegener. 2013 Oct 04;2(1):20
pubmed: 24093918
J Histochem Cytochem. 1983 Jan;31(1):101-9
pubmed: 6187796
Int J Mol Sci. 2019 Feb 08;20(3):
pubmed: 30744070
Mol Neurobiol. 2013 Jun;47(3):1081-92
pubmed: 23389286
Cancer. 2000 May 1;88(9):2154-63
pubmed: 10813729
J Neuroimmunol. 2005 Aug;165(1-2):114-20
pubmed: 15949848
J Biol Chem. 2010 Sep 3;285(36):28261-74
pubmed: 20592036
Cancer Chemother Pharmacol. 1994;33(4):325-30
pubmed: 8281627
Micron. 2004;35(4):287-96
pubmed: 15003616

Auteurs

Larisa Ryskalin (L)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126 Pisa, Italy.

Rosangela Ferese (R)

Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Neuromed, Via Atinense 18, 86077 Pozzilli, Italy.

Gabriele Morucci (G)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126 Pisa, Italy.

Francesca Biagioni (F)

Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Neuromed, Via Atinense 18, 86077 Pozzilli, Italy.

Carla L Busceti (CL)

Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Neuromed, Via Atinense 18, 86077 Pozzilli, Italy.

Fabrizio Michetti (F)

Departmentof Neuroscience, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy.
IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Via Olgettina 6, 20121 Milan, Italy.

Paola Lenzi (P)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126 Pisa, Italy.

Alessandro Frati (A)

Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Neuromed, Via Atinense 18, 86077 Pozzilli, Italy.
Neurosurgery Division, Human Neurosciences Department, Sapienza University, 00135 Roma, Italy.

Francesco Fornai (F)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126 Pisa, Italy.
Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Neuromed, Via Atinense 18, 86077 Pozzilli, Italy.

Classifications MeSH